The clinical relevance of CDK9 overexpression in colorectal cancer samples is yet to be determined as it is unclear if CDK9 acts as a tumor promotor in colorectal cancer or if the overexpression of CDK9 is a consequence of the cancer genome. This evidence concerns the gene CDK9 and neoplasm.